AEPGX
Price
$63.78
Change
-$0.26 (-0.41%)
Updated
Nov 19 closing price
Net Assets
132.22B
FCIUX
Price
$17.20
Change
-$0.06 (-0.35%)
Updated
Nov 19 closing price
Net Assets
731.3M
Interact to see
Advertisement

AEPGX vs FCIUX

Header iconAEPGX vs FCIUX Comparison
Open Charts AEPGX vs FCIUXBanner chart's image
American Funds EUPAC A
Price$63.78
Change-$0.26 (-0.41%)
VolumeN/A
Net Assets132.22B
NYLI PineStone International Equity Cl I
Price$17.20
Change-$0.06 (-0.35%)
VolumeN/A
Net Assets731.3M
AEPGX vs FCIUX Comparison Chart in %
View a ticker or compare two or three
VS
AEPGX vs. FCIUX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Hold and FCIUX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 132B vs. FCIUX (731M). AEPGX pays higher dividends than FCIUX: AEPGX (0.64) vs FCIUX (0.58). AEPGX was incepted earlier than FCIUX: AEPGX (42 years) vs FCIUX (8 years). FCIUX (0.93) is less costly to investors than AEPGX (0.83). AEPGX is a more actively managed with annual turnover of: 35.00 vs. FCIUX (10.00). AEPGX has a lower initial minimum investment than FCIUX: AEPGX (250) vs FCIUX (1000000). AEPGX annual gain was more profitable for investors over the last year : 13.03 vs. FCIUX (5.19). FCIUX return over 5 years is better than : 28.37 vs. AEPGX (3.80).
AEPGXFCIUXAEPGX / FCIUX
Total Expense Ratio0.830.8598%
Annual Report Gross Expense Ratio0.830.9389%
Fund Existence42 years8 years-
Gain YTD18.7275.977313%
Front Load6%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets132B731M18,057%
Annual Yield % from dividends0.640.58110%
Returns for 1 year13.035.19251%
Returns for 3 years31.3233.1295%
Returns for 5 years3.8028.3713%
Returns for 10 years38.74N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCRX1.030.04
+4.03%
TScan Therapeutics
GPATU10.72N/A
N/A
GP-Act III Acquisition Corp
SFD21.41-0.16
-0.72%
Smithfield Foods Inc
IMNM17.67-0.19
-1.06%
Immunome
ENTA12.13-0.23
-1.86%
Enanta Pharmaceuticals